Next Article in Journal
Follow-Up for Women after Treatment for Cervical Cancer
Previous Article in Journal
Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Open AccessLetter

Adjuvant Interferon Alfa for Melanoma

British Columbia Cancer Agency, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
Curr. Oncol. 2010, 17(3), 6-7; https://doi.org/10.3747/co.v17i3.511
Received: 1 May 2010 / Revised: 3 May 2010 / Accepted: 6 May 2010 / Published: 1 June 2010
Note: In lieu of an abstract, this is an excerpt from the first page.

The author poses the question “Why did these study results not lead to a global consensus about interferon treatment as standard of care?” [...]
Keywords: melanoma; adjuvant; interferon melanoma; adjuvant; interferon
MDPI and ACS Style

Wilson, K.S.; Attwell, A. Adjuvant Interferon Alfa for Melanoma. Curr. Oncol. 2010, 17, 6-7. https://doi.org/10.3747/co.v17i3.511

AMA Style

Wilson KS, Attwell A. Adjuvant Interferon Alfa for Melanoma. Current Oncology. 2010; 17(3):6-7. https://doi.org/10.3747/co.v17i3.511

Chicago/Turabian Style

Wilson, Kenneth S.; Attwell, Andrew. 2010. "Adjuvant Interferon Alfa for Melanoma" Curr. Oncol. 17, no. 3: 6-7. https://doi.org/10.3747/co.v17i3.511

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop